ANDA 91397, held by Baxter Hlthcare Corp. Levofloxacin.
As of Nov 16, 2026, ANDA 91397 (Levofloxacin In Dextrose 5% In Plastic Container), held by Baxter Hlthcare Corp, was first approved by FDA on Aug 8, 2013, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 8, 2013 | Original application | Approved | None posted |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 250MG/50ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 500MG/100ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 750MG/150ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Sep 20, 2024 | Supplement 24Labeling · Standard review | Approved | None posted |
| May 6, 2019 | Supplement 18Labeling · Standard review | Approved | None posted |
| May 6, 2019 | Supplement 19Labeling · Standard review | Approved | None posted |
| Oct 18, 2018 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 15, 2018 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 15, 2018 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 20, 2014 | Supplement 3Manufacturing | Approved | None posted |
| Sep 23, 2014 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 23, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 8, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters